324 related articles for article (PubMed ID: 12502747)
21. STAT3 down-regulates the expression of cyclin D during liver development.
Matsui T; Kinoshita T; Hirano T; Yokota T; Miyajima A
J Biol Chem; 2002 Sep; 277(39):36167-73. PubMed ID: 12147685
[TBL] [Abstract][Full Text] [Related]
22. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
23. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH
Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970
[TBL] [Abstract][Full Text] [Related]
24. Involvement of the D-type cyclins in germ cell proliferation and differentiation in the mouse.
Beumer TL; Roepers-Gajadien HL; Gademan IS; Kal HB; de Rooij DG
Biol Reprod; 2000 Dec; 63(6):1893-8. PubMed ID: 11090462
[TBL] [Abstract][Full Text] [Related]
25. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation.
Bartkova J; Lukas J; Strauss M; Bartek J
Oncogene; 1998 Aug; 17(8):1027-37. PubMed ID: 9747882
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
[TBL] [Abstract][Full Text] [Related]
28. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
[TBL] [Abstract][Full Text] [Related]
29. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
32. Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.
Pogoriler J; Millen K; Utset M; Du W
Development; 2006 Oct; 133(19):3929-37. PubMed ID: 16943274
[TBL] [Abstract][Full Text] [Related]
33. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells.
Mori N; Fujii M; Hinz M; Nakayama K; Yamada Y; Ikeda S; Yamasaki Y; Kashanchi F; Tanaka Y; Tomonaga M; Yamamoto N
Int J Cancer; 2002 May; 99(3):378-85. PubMed ID: 11992406
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of d-type cyclins in podocytes in vitro and in vivo.
Petermann A; Hiromura K; Pippin J; Blonski M; Couser WG; Kopp J; Mundel P; Shankland SJ
Am J Pathol; 2004 Apr; 164(4):1417-24. PubMed ID: 15039229
[TBL] [Abstract][Full Text] [Related]
35. Requirement for cyclin D3 in lymphocyte development and T cell leukemias.
Sicinska E; Aifantis I; Le Cam L; Swat W; Borowski C; Yu Q; Ferrando AA; Levin SD; Geng Y; von Boehmer H; Sicinski P
Cancer Cell; 2003 Dec; 4(6):451-61. PubMed ID: 14706337
[TBL] [Abstract][Full Text] [Related]
36. Alternative mammary oncogenic pathways are induced by D-type cyclins; MMTV-cyclin D3 transgenic mice develop squamous cell carcinoma.
Pirkmaier A; Dow R; Ganiatsas S; Waring P; Warren K; Thompson A; Hendley J; Germain D
Oncogene; 2003 Jul; 22(28):4425-33. PubMed ID: 12853979
[TBL] [Abstract][Full Text] [Related]
37. Selective usage of D-type cyclins in lymphoid malignancies.
Suzuki R; Kuroda H; Komatsu H; Hosokawa Y; Kagami Y; Ogura M; Nakamura S; Kodera Y; Morishima Y; Ueda R; Seto M
Leukemia; 1999 Sep; 13(9):1335-42. PubMed ID: 10482983
[TBL] [Abstract][Full Text] [Related]
38. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
Greider C; Chattopadhyay A; Parkhurst C; Yang E
Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
[TBL] [Abstract][Full Text] [Related]
39. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P
Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D2 controls B cell progenitor numbers.
Mohamedali A; Soeiro I; Lea NC; Glassford J; Banerji L; Mufti GJ; Lam EW; Thomas NS
J Leukoc Biol; 2003 Dec; 74(6):1139-43. PubMed ID: 14612431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
